Wen, Xi-zhi
Pan, Qiu-zhong http://orcid.org/0000-0002-2145-535X
Xu, Bu-shu
Xiao, Wei
Weng, De-sheng
Zhao, Jing-jing
Xu, Hai-rong
Huang, Zhen
Niu, Xiao-hui
Zhang, Xing http://orcid.org/0000-0003-2665-6940
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma
https://doi.org/10.1007/s00280-021-04371-6
Article History
Received: 5 July 2021
Accepted: 1 November 2021
First Online: 13 January 2022
Declarations
:
: The authors declare that they have no completing interests.
: The study was approved by the Scientific and Ethics Committees of Sun Yat-sen University Cancer Center (Number B2018-102-05).
: Each patient signed a written informed consent before participating to this study (Trial Registration: ChiCTR, ChiCTR1900021550).